Landmarks in BPH--from aetiology to medical and surgical management
- PMID: 24445912
- DOI: 10.1038/nrurol.2013.318
Landmarks in BPH--from aetiology to medical and surgical management
Abstract
Clinicians treat the symptoms associated with BPH on a daily basis. Although BPH is nearly universal with age, not all men develop lower urinary tract symptoms. Over the past 100 years, several notable advances in the field of urology have not only improved our understanding of the aetiology and natural history of this common disease, but have also facilitated the development of therapeutics to effectively manage BPH-related symptoms. The high quality of modern-day diagnosis, as well as medical and surgical treatment for BPH, is a testimony to centuries of observation and decades of scientific research.
Similar articles
-
Management of symptomatic BPH in France: who is treated and how?Eur Urol. 1999;36 Suppl 3:14-20. doi: 10.1159/000052344. Eur Urol. 1999. PMID: 10559626
-
[Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].Prog Urol. 2015 Jun;25(7):404-12. doi: 10.1016/j.purol.2015.02.008. Epub 2015 Apr 2. Prog Urol. 2015. PMID: 25841758 French.
-
[Relationship of socioeconomic factors with medical utilization for lower urinary tract symptoms and benign prostatic hyperplasia in a South Korean community].J Prev Med Public Health. 2006 Mar;39(2):141-8. J Prev Med Public Health. 2006. PMID: 16615269 Korean.
-
Early treatment of benign prostatic hyperplasia: implications for reducing the risk of permanent bladder damage.Drugs Aging. 2003;20(3):185-95. doi: 10.2165/00002512-200320030-00003. Drugs Aging. 2003. PMID: 12578399 Review.
-
[Treatment of benign prostatic hyperplasia in geriatric patients-use and limitations of existing guidelines].Urologe A. 2019 Sep;58(9):1029-1038. doi: 10.1007/s00120-019-0988-0. Urologe A. 2019. PMID: 31451881 Review. German.
Cited by
-
Recent advances in the understanding of male lower urinary tract symptoms (LUTS).F1000Res. 2016 Apr 21;5:F1000 Faculty Rev-715. doi: 10.12688/f1000research.8638.1. eCollection 2016. F1000Res. 2016. PMID: 27134738 Free PMC article. Review.
-
Gut microbiome: a novel preventive and therapeutic target for prostatic disease.Front Cell Infect Microbiol. 2024 Jul 29;14:1431088. doi: 10.3389/fcimb.2024.1431088. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39135640 Free PMC article. Review.
-
BPH: Why Do Patients Fail Medical Therapy?Curr Urol Rep. 2019 Jun 6;20(7):40. doi: 10.1007/s11934-019-0899-z. Curr Urol Rep. 2019. PMID: 31168725 Review.
-
Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy.World J Urol. 2018 Apr;36(4):575-584. doi: 10.1007/s00345-018-2220-z. Epub 2018 Feb 14. World J Urol. 2018. PMID: 29445846 Review.
-
Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate.Prostate. 2020 Sep;80(12):938-949. doi: 10.1002/pros.24026. Epub 2020 Jun 16. Prostate. 2020. PMID: 32542667 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous